Arbutus Biopharma Corp (NASDAQ:ABUS)

Delayed Data
As of May 20
 +0.08 / +3.42%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Arbutus Biopharma Corp have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +147.93% increase from the last price of 2.42.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Arbutus Biopharma Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.73%
Growthannually 37.83%


Growthquarterly -46.21%
Growthannually 191.91%
Key to the earnings and sales forecast charts.